The Congress Management Committee is pleased to announce the following confirmed keynote speakers:


Dr Peter Hotez

Peter J. Hotez, M.D., Ph.D., is the founding Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. He is also President of the Sabin Vaccine Institute, Director of the Texas Children’s Hospital Center for Vaccine Development and the Baker Institute Fellow in Disease and Poverty at Rice University.

Dr. Hotez is an internationally-recognized research investigator in neglected tropical disease vaccine development and a renowned global health advocate. He leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, and Chagas disease, diseases affecting hundreds of millions of children and adults worldwide. The hookworm vaccine is currently in clinical trials. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for more than 100 million people.

Dr. Hotez has authored more than 300 original papers, including lead articles in the New England Journal of Medicine, Lancet, Science, and Scientific American, and more than three dozen op-ed pieces or editorials, including pieces in the New York Times, LA Times, and the Washington Post and over 60 textbook chapters. He has also authored or edited 10 books, including the acclaimed Forgotten People, Forgotten Diseases (ASM Press). In 2015 he was appointed by the White House and State Department as United States Science Envoy.

 John Reeder

Professor John Reeder

Professor John Reeder is Director of TDR, the Special Programme for Research and Training in Tropical Diseases,  at the World Health Organization in Geneva. He was previously Director of the Centre for Population Health and Head of the Office of International Health Research at the Burnet Institute, Melbourne and an NH&MRC Senior Research Fellow . Prior to this he was Director of the Papua New Guinea Institute of Medical Research for several years, where he worked on translating scientific findings into policy for improved health across research programmes in mosquito-borne diseases, respiratory disease, sexual health, disease surveillance, infectious diseases and therapies, and operational/implementation research. 

John began his career in medical microbiology laboratories in the United Kingdom and then moved to health training as a development volunteer in the Highlands of PNG, later working with the renowned malaria research team at the Walter and Eliza Hall Institute. He maintains research interests in malaria and other agents of global health significance, such as tuberculosis, NTDs and HIV.  He has published around 150 scientific papers that span basic laboratory research to large community-based field studies.

 Kevin Marsh

Professor Kevin Marsh

Kevin Marsh is a senior advisor at the African Academy of Sciences and Professor of Tropical Medicine at the University of Oxford. He qualified in medicine at the University of Liverpool in 1978 and began his research career at the Medical Research Council Unit in the Gambia. From 1985-89 he was at the Institute of Molecular Medicine in Oxford and in 1989 established with colleagues a series of research projects on the clinical epidemiology and immunology of malaria in Kilifi on the Kenyan coast. These have subsequently developed into an international programme (the KEMRI Wellcome Trust Research Programme) involving around 800 staff working across a number of countries in East Africa of which he was director until August 2014. 

He is currently supporting the development of a new platform for the acceleration of science in Africa through the African Academy of Sciences. He is chair of the WHO Malaria Policy Advisory Committee and is a member of a number of international advisory committees relating to malaria and to global health research. He was elected a fellow of the Academy of Medical Sciences in 2004 and was awarded the Prince Mahidol prize for medicine in 2010. 

 BT photo (220x280)

Dr BT Slingsby

BT Slingsby, MD, PhD, MPH, is CEO and Executive Director of the Global Health Innovative Technology (GHIT) Fund, a public-private partnership fund that leverages Japanese innovation and leadership to advance research and development (R&D) for novel health technologies for the developing world. Previously, he led Global Access Strategies for Eisai & Co., where he developed new business models for R&D and market access in the developing world. Prior to joining Eisai & Co., he helped launch various start-ups in Japan and the U.S. Dr. Slingsby has published numerous articles on health in both Japanese and American literature and co-authored the first textbook on bioethics in Asia. He holds academic positions at the University of Tokyo Graduate School of Medicine and Kyoto University Graduate School of Medicine and previously served as Invited Associate Professor at Keio University School of Medicine. Dr. Slingsby obtained his MD from The George Washington University School of Medicine and Health Sciences, his doctoral degree from the University of Tokyo Graduate School of Medicine, and his Masters of Public Health from Kyoto University Graduate School of Medicine. He is a former professional triathlete and member of the U.S. World Cup Team.

 Sharon Lewin

 Professor Sharon Lewin

Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; consultant infectious diseases physician, Alfred Hospital, Melbourne, Australia; and an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist. She leads a large multi-disciplinary research team that focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding  a cure for HIV infection.

She was the local co-chair of the XXth International AIDS Conference (AIDS2014) which was held in Melbourne July 2014 which was the largest health conference ever held in Australia. In 2014, she was named Melburnian of the Year, an annual award from the City of Melbourne to an inspirational role model who has made an outstanding contribution to the city in their chosen field.

She is active internationally in advocating for increased investment from the public and private sector in HIV cure research and is on the leadership team of the International AIDS Society’s Strategy Towards an HIV Cure. She is a member of the Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmitted Infections, which is the peak advisory body on HIV infection to the Australian Minister of Health.

 Early Career Keynote Speakers:


Sylvie Manguin 

 Professor Sylvie Manguin

Sylvie Manguin (DR1, PhD, HDR) is a Full Research Professor at the French Institute of Research for Development (IRD) in Montpellier and lecturer at the University of Montpellier (France) and Kasetsart University in Bangkok (Thailand). She is a medical entomologist specialized in mosquito-borne diseases. After a postdoctorate position in USA (UC Riverside, USDA Beltsville) in 1988-1990, she became a Research Assistant at the US Medical University of USUHS (Bethesda, MD) from 1990 to 1995 during which she studied population genetics of malaria vectors from Latin America. In 1995, she joined IRD (Montpellier) to work on Asian and African malaria vectors, especially on molecular species identification, phylogeny-phylogeography, and resistance to insecticides. As a Research Professor since 2004, she specialized on the molecular study of Anopheles and Aedes mosquitoes, transmission of pathogenic agents, microbiota analysis of malaria vectors, and human antibody response to Anopheles saliva proteins for evaluating the efficacy of vector control programs. She is the editor of a book published in 2013 on “Anopheles mosquitoes: New insights into malaria vectors” (InTech Open Access). She is the Secretary General of the International Federation of Tropical Medicine (IFTM) and member of the editorial boards of the Malaria Journal and Acta Tropica.


 Photo Charlotte Hall

 Dr Charlotte Hall

Charlotte is a British specialty trainee in infectious diseases and general medicine. Her love of medicine in the tropics has taken her to practise in many destinations including Vanuatu, the Thai-Burma border, Cambodia, Kenya, South Africa, and, most recently, in Timor-Leste.
She has particular interests in TB, HIV, and viral hepatitis. Recent publications include a study of the prevalence of hepatitis B in pregnant women in Timor-Leste and an analysis of the challenges of delivering isoniazid preventive therapy for TB to children in Timor-Leste. The latter, along with work training healthcare workers to deliver a community-based model of contact tracing and IPT, formed the focus of her MPH dissertation. 
She is a member of the Bairo Pite Clinic (Timor-Leste) Medical Advisory Committee and is working on capacity building in the HIV programme as well as being the PI on a 5-year prospective study of TB epidemiology. She would ultimately like to undertake a mixture of clinical work, and operational research and capacity building activities focused on understanding the health needs in low-income settings and developing health systems to meet these.

 Dr Myrielle Dupont-Rouzeyrol

 Dr Myrielle Dupont – Rouzeyrol

Myrielle Dupont-Rouzeyrol, PhD, is a research scientist at Institut Pasteur in New Caledonia. She is leading the Research and Expertise Unit on Dengue and Arboviruses. Her research interests are focusing on diagnostic, molecular epidemiology and evolution of arboviruses (Dengue, Chikungunya and Zika). She is also investigating the interactions between arboviruses and vectors with applications to New Caledonia and the Pacific region. Within the International Institut Pasteur Network, she is leading a project on Zika virus: molecular evolution and vector competence.